ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (“Aspen Holdings”) Registration number: 1985/002935/06 Share code: APN ISIN: ZAE000066692 LEI: 635400ZYSN1IRD5QWQ94 and its subsidiaries (collectively “Aspen” or “the Company”) BROAD-BASED BLACK ECONOMIC EMPOWERMENT CERTIFICATE FOR THE YEAR ENDED 30 JUNE 2022 Further to the announcement regarding the release of the Integrated Report for the year ended 30 June 2022 and Notice of AGM released on 28 October 2022, shareholders are hereby notified that in accordance with the JSE Listings Requirements, the Company's B-BBEE compliance report in terms of section 13G(2) of the Broad-Based Black Economic Empowerment Act 53 of 2003, read with the Broad-Based Black Economic Empowerment Act 46 of 2013, has been submitted to the BEE Commission and is available on the Company’s website at https://www.aspenpharma.com/responsible-corporate-citizenship/ under the FY2022 tab. Durban 10 November 2022 Sponsor Investec Bank Limited